Safety & Quality
Onyx BioLabs — Safety, Quality & Scientific Evidence
Available research does not establish the human safety, effectiveness, optimal dosage, or long-term outcomes of this exact finished blend.
Manufacturer purity claims
According to the manufacturer's displayed materials, the seller advertises at least 99% HPLC purity and shows a batch report reference of GLOW0526-70-1 with a reported result of 99.714%. These figures have not been independently authenticated.
An HPLC purity result alone does not establish:
- Sterility
- Endotoxin status
- Absence of all contaminants
- Exact quantity of each ingredient
- Human safety
- Clinical effectiveness
Claim versus evidence
| Claim | Evidence status |
|---|---|
| Skin firmness and collagen | Research interest exists, but the effectiveness of this blend is unproven. |
| Tissue repair | Experimental research exists, but robust clinical evidence for this product is lacking. |
| Angiogenesis | A biological research topic, not a guaranteed benefit. |
| Cellular movement | Related research exists, but clinical benefits from this blend are not established. |
| Combined peptide synergy | Not established by reliable controlled human trials. |
Regulatory context
The FDA has identified potential concerns involving immunogenicity, aggregation, peptide-related impurities, and limited human data in relevant compounding contexts. This does not mean every vial is contaminated, and legal status varies by country.
Read the FDA information
View Product Listing →Product information
View the seller's listing
Provided for product information only. This link is not a medical recommendation.